Secreted Threonyl-tRNA synthetase stimulates endothelial cell migration and angiogenesis

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Williams, Tamara F ^a,b   Mirando, Adam C ^a   Wilkinson, Barrie ^c   Francklyn, Christopher S ^a,b   Lounsbury, Karen M ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c BIOTICA TECHNOLOGY LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; AUTACOID; PEPTIDE FRAGMENT; THREONINE TRANSFER RNA LIGASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; ENZYMOLOGY; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SECRETION (PROCESS); UMBILICAL VEIN ENDOTHELIAL CELL; UNFOLDED PROTEIN RESPONSE;

ANGIOGENESIS INHIBITORS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; THREONINE-TRNA LIGASE; TUMOR NECROSIS FACTOR-ALPHA; UNFOLDED PROTEIN RESPONSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MLCS; MLOWN;

EID: 84874333750     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01317     Document Type: Article

References (37)

1. Sampath, P. et al. Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation. Cell 119, 195-208 (2004).
2. Wakasugi, K. & Schimmel, P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284, 147-51 (1999).
3. Park, S. G., Ewalt, K. L. & Kim, S. Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 30, 569-74 (2005).
4. Greenberg, Y. et al. The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells. FASEB J 22, 1597-605 (2008).
5. Jordanova, A. et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38, 197-202 (2006).
6. Antonellis, A. & Green, E. D. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 9, 87-107 (2008).
7. Puffenberger, E. G. et al. Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One 7, e28936 (2012).
8. Wakasugi, K. et al. A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Natl Acad Sci U S A 99, 173-7 (2002).
9. Kim, S., You, S. & Hwang, D. Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nat Rev Cancer 11, 708-18 (2011).
10. Cassavaugh, J. & Lounsbury, K. M. Hypoxia-mediated biological control. J Cell Biochem 112, 735-44 (2011).
11. Funahashi, Y. et al. Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor. Oncol Res 11, 319-29 (1999).
12. Habibi, D. et al. Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia. Invest New Drugs 30, 1361-70 (2011).
13. Harisi, R. et al. Differential inhibition of single and cluster type tumor cell migration. Anticancer Res 29, 2981-5 (2009).
14. Moss, S. J. et al. Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analogues. Chem Commun (Camb), 2341-3 (2006).
15. Wilkinson, B. et al. Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain. Bioorg Med Chem Lett 16, 5814-7 (2006).
16. Labirua, A. & Lundberg, I. E. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol 22, 633-8 (2010).
17. Sigurgeirsson, B., Lindelof, B., Edhag, O. & Allander, E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326, 363-7 (1992).
18. Suber, T. L., Casciola-Rosen, L. & Rosen, A. Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol 4, 201-9 (2008).
19. Park, S. G. et al. Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc Natl Acad Sci U S A 102, 6356-61 (2005).
20. Tzima, E. & Schimmel, P. Inhibition of tumor angiogenesis by a natural fragment of a tRNA synthetase. Trends Biochem Sci 31, 7-10 (2006).
21. Ghanipour, A. et al. The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer. Cancer Epidemiol Biomarkers Prev 18, 2949-56 (2009).
22. Arif, A. et al. Two-site phosphorylation of EPRS coordinates multimodal regulation of noncanonical translational control activity. Mol Cell 35, 164-80 (2009).
23. Wakabayashi, T. et al. Borrelidin is an angiogenesis inhibitor; disruption of angiogenic capillary vessels in a rat aorta matrix culture model. J Antibiot (Tokyo) 50, 671-6 (1997).
24. Kawamura, T. et al. Anti-angiogenesis effects of borrelidin are mediated through distinct pathways: threonyl-tRNA synthetase and caspases are independently involved in suppression of proliferation and induction of apoptosis in endothelial cells. J Antibiot (Tokyo) 56, 709-15 (2003).
25. Woolard, J. et al. Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chem Sci 2011, 273-278 (2011).
26. Mathews, M. B., Reichlin, M., Hughes, G. R. & Bernstein, R. M. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 160, 420-34 (1984).
27. De Paepe, B., Creus, K. K. & De Bleecker, J. L. The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy. Clin Dev Immunol 2012, 369432 (2012).
28. Howard, O. M. Z. et al. Histidyl-tRNA Synthetase and Asparaginyl-tRNA Synthetase, Autoantigens in Myositis, Activate Chemokine Receptors on T Lymphocytes and Immature Dendritic Cells. The Journal of Experimental Medicine 196, 781-791 (2002).
29. Bovee, M. L., Pierce, M. A. & Francklyn, C. S. Induced fit and kinetic mechanism of adenylation catalyzed by Escherichia coli threonyl-tRNA synthetase. Biochemistry 42, 15102-13 (2003).
30. Arnaoutova, I. & Kleinman, H. K. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5, 628-35 (2010).
31. Cassavaugh, J. M. et al. Negative regulation of HIF-1alpha by an FBW7-mediated degradation pathway during hypoxia. J Cell Biochem 112, 3882-90 (2011).
32. Longair, M. H., Baker, D. A. & Armstrong, J. D. Simple Neurite Tracer: open source software for reconstruction, visualization and analysis of neuronal processes. Bioinformatics 27, 2453-4 (2011).
33. Ahmed, S. A., Gogal, R. M. Jr. & Walsh, J. E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 170, 211-24 (1994).
34. Dieterich, D. C. et al. Labeling, detection and identification of newly synthesized proteomes with bioorthogonal non-canonical amino-acid tagging. Nat Protoc 2, 532-40 (2007).
35. Lounsbury, K. M., Beddow, A. L. & Macara, I. G. A family of proteins that stabilize the Ran/TC4 GTPase inits GTP-bound conformation. JBiol Chem 269, 11285-90 (1994).
36. Ribatti, D., Nico, B., Vacca, A. & Presta, M. The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 1, 85-91 (2006).
37. Svensson, K. J. et al. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U S A 108, 13147-52 (2011).